Johnson & Johnson (J&J) has agreed to pay $5.5 billion to resolve the majority of its remaining talc-related lawsuits in the United States, marking a major step toward ending a legal battle that has lasted more than 15 years.
The proposed settlement, announced on Monday, is subject to several conditions, including the participation of plaintiff law firms representing at least 95% of the remaining ovarian cancer claims pending in federal and state courts.